Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial (vol 180, pg 1345, 2020)

被引：0
|
作者：
Hermine, O.
Mariette, X.
Tharaux, P-L
Resche-Rigon, M.
Porcher, R.
Ravaud, p
机构：
来源：
JAMA INTERNAL MEDICINE | 2021年 / 181卷 / 07期
关键词：
D O I：
10.1001/jamainternmed.2021.3845
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1021 / 1021
页数：1
相关论文
共 50 条
  • [1] Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
    Hermine, Olivier
    Mariette, Xavier
    Tharaux, Pierre-Louis
    Resche-Rigon, Matthieu
    Porcher, Raphael
    Ravaud, Philippe
    JAMA INTERNAL MEDICINE, 2021, 181 (01) : 32 - 40
  • [2] Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial (vol 181, pg 32, 2021)
    Hermine, O.
    Mariette, X.
    Tharaux, P-L
    Resche-Rigon, M.
    Porcher, R.
    Ravaud, P.
    JAMA INTERNAL MEDICINE, 2021, 181 (01) : 144 - 144
  • [3] Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
    Salvarani, Carlo
    Dolci, Giovanni
    Massari, Marco
    Merlo, Domenico Franco
    Cavuto, Silvio
    Savoldi, Luisa
    Bruzzi, Paolo
    Boni, Fabrizio
    Braglia, Luca
    Turra, Caterina
    Ballerini, Pier Ferruccio
    Sciascia, Roberto
    Zammarchi, Lorenzo
    Para, Ombretta
    Scotton, Pier Giorgio
    Inojosa, Walter Omar
    Ravagnani, Viviana
    Salerno, Nicola Duccio
    Sainaghi, Pier Paolo
    Brignone, Alessandro
    Codeluppi, Mauro
    Teopompi, Elisabetta
    Milesi, Maurizio
    Bertomoro, Perla
    Claudio, Norbiato
    Salio, Mario
    Falcone, Marco
    Cenderello, Giovanni
    Donghi, Lorenzo
    Del Bono, Valerio
    Colombelli, Paolo Luigi
    Angheben, Andrea
    Passaro, Angelina
    Secondo, Giovanni
    Pascale, Renato
    Piazza, Ilaria
    Facciolongo, Nicola
    Costantini, Massimo
    JAMA INTERNAL MEDICINE, 2021, 181 (01) : 24 - 31
  • [4] Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
    Aomar-Millan, Ismael F.
    Salcaterra, Juan
    Alvarez, Enrique Raya
    MEDICINA CLINICA, 2022, 159 (08): : E54 - E54
  • [5] Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
    Cardona-Pascual, Ignacio
    Berlana, David
    Martinez-Valle, Ferran
    Campany-Herrero, David
    Bruno Montoro-Ronsano, Jose
    MEDICINA CLINICA, 2022, 158 (07): : 301 - 307
  • [6] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Rosas, Ivan O.
    Diaz, George
    Gottlieb, Robert L.
    Lobo, Suzana M.
    Robinson, Philip
    Hunter, Bradley D.
    Cavalcante, Adilson W.
    Overcash, J. Scott
    Hanania, Nicola A.
    Skarbnik, Alan
    Garcia-Diaz, Julia
    Gordeev, Ivan
    Carratala, Jordi
    Gordon, Oliver
    Graham, Emily
    Lewin-Koh, Nicholas
    Tsai, Larry
    Tuckwell, Katie
    Cao, Huyen
    Brainard, Diana
    Olsson, Julie K.
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1258 - 1270
  • [7] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
    Ivan O. Rosas
    George Diaz
    Robert L. Gottlieb
    Suzana M. Lobo
    Philip Robinson
    Bradley D. Hunter
    Adilson W. Cavalcante
    J. Scott Overcash
    Nicola A. Hanania
    Alan Skarbnik
    Julia Garcia-Diaz
    Ivan Gordeev
    Jordi Carratalà
    Oliver Gordon
    Emily Graham
    Nicholas Lewin-Koh
    Larry Tsai
    Katie Tuckwell
    Huyen Cao
    Diana Brainard
    Julie K. Olsson
    Intensive Care Medicine, 2021, 47 : 1258 - 1270
  • [8] Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia Reply
    Berlana, David
    Cardona-Pascual, Ignacio
    Montoro-Ronsano, J. Bruno
    MEDICINA CLINICA, 2022, 159 (08): : E55 - E55
  • [9] Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Darazam, Ilad Alavi
    Shokouhi, Shervin
    Mardani, Masoud
    Pourhoseingholi, Mohamad Amin
    Rabiei, Mohammad Mahdi
    Hatami, Firouze
    Shabani, Minoosh
    Moradi, Omid
    Gharehbagh, Farid Javandoust
    Irvani, Seyed Sina Naghibi
    Amirdosara, Mahdi
    Hajiesmaeili, Mohammadreza
    Rezaei, Omidvar
    Khoshkar, Ali
    Lotfollahi, Legha
    Gachkar, Latif
    Dehbsneh, Hadiseh Shabanpour
    Khalili, Negar
    Soleymaninia, Azam
    Kusha, Akram Hoseyni
    Shoushtari, Maryam Taleb
    Torabinavid, Parham
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [10] High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
    Naik, Naveen B.
    Puri, Goverdhan D.
    Kajal, Kamal
    Mahajan, Varun
    Bhalla, Ashish
    Kataria, Sandeep
    Singla, Karan
    Panigrahi, Pritam
    Singh, Ajay
    Lazar, Michelle
    Chander, Anjuman
    Ganesh, Venkata
    Hazarika, Amarjyoti
    Suri, Vikas
    Goyal, Manoj K.
    Pandey, Vijayant Kumar
    Kaloria, Narender
    Samra, Tanvir
    Saini, Kulbhushan
    Soni, Shiv L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
12345